United States· US:0187-1231_c8ba6520-445a-4934-85f4-6f706cb21585
Cesamet
A nabilone product containing nabilone, registered in United States by Bausch Health US LLC. The same ATC class is registered in 4 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Nabilone is registered in 4 of 19 countries.
Countries holding a registration under ATC A04AD11 (nabilone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Nabilone · ATC A04AD11
4 / 19 countries
- Canada
- Germany
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NABILONE
- Manufacturer
- Bausch Health US LLC
- Country
- United States (US)
- ATC code
- A04AD11
- ATC class
- Nabilone
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1101871231501 BOTTLE in 1 CARTON (0187-1231-50) / 50 CAPSULE in 1 BOTTLE
- ndc110187-1231-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
361 interactions on record for nabilone.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Nabilone · interactions on record
361 records
- 6 severe
- 355 moderate
Most severe, free to view
- Sodium oxybateN01AX11severe
- DextropropoxypheneN02AC04severe
- BuprenorphineN02AE01severe
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Nabilone in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNabilone 1mg capsulesAlliance Healthcare (Distribution) Ltd
- CanadaCESAMETBAUSCH HEALTH, CANADA INC.
- GermanyCanemesWalter Ritter Gmbh + Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Canemes
- Germany · Canemes
- United Kingdom (Northern Ireland) · Nabilone, Nabilone Brown & Burk Uk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9e02187-84fd-4d70-9997-43aa457e4f65 GET /v1/drugs/e9e02187-84fd-4d70-9997-43aa457e4f65?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1",
"substance": "NABILONE",
"productndc": "0187-1231",
"dosage_form": "CAPSULE",
"dea_schedule": "CII",
"strength_unit": "mg/1",
"application_number": "NDA018677",
"marketing_category": "NDA"
}See everything about nabilone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.